Workplace spirometry monitoring for respiratory disease prevention: A methods review

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 7, 2010, Pages 796-805

  Hnizdo, Eva ^a   Glindmeyer, H W ^b   Petsonk, E L ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic obstructive pulmonary disease; Medical screening; Periodic spirometry; Spirometry; Spirometry monitoring

Indexed keywords

ACCURACY; ASTHMA; BLUE COLLAR WORKER; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; EXERCISE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH EDUCATION; HUMAN; LUNG FUNCTION; MEDICAL DECISION MAKING; MONITORING; MORBIDITY; MORTALITY; NUTRITION; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PNEUMONIA; PRIORITY JOURNAL; QUALITY CONTROL; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; SMOKING; SOCIAL STATUS; SPIROMETRY; TUBERCULOSIS; WORKPLACE; COMPUTER ASSISTED DIAGNOSIS; DECISION MAKING; LUNG DISEASES; LUNG FUNCTION TEST; MASS SCREENING; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STANDARDS;

DECISION MAKING; DIAGNOSIS, COMPUTER-ASSISTED; HUMANS; LUNG DISEASES; MASS SCREENING; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SPIROMETRY; WORKPLACE;

EID: 77953630785     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Loeppke R, Taitel M, Richling D, et al. Health and productivity as a business strategy. J Occup Environ Med 2007; 49: 712-721.
2. Loeppke R, Taitel M, Haufle V, Parry T, Kessler R C, Jinnett K. Health and productivity as a business strategy: a multiemployer study. J Occup Environ Med 2009; 51: 411-428.
3. Celli B R, MacNee W, and committee members. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932-946.
4. Pauwels R A, Buist S A, Calverley P M A, Jenkins C R, Hurd S S, on behalf of the GOLD Scientifi c Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 1256-1276.
5. Mannino D M, Reichert M M, Davis K J. Lung function decline and outcomes in an adult population. Am J Respir Crit Care Med 2006; 173: 985-990.
6. Hnizdo E, Sullivan P A, Bang K M, Wagner G. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2002; 156: 738-746.
7. Darkow T, Chastek B J, Shah H, Phillips A L. Health care cost among individuals with chronic obstructive disease within several large, multi-state employers. J Occup Environ Med 2008; 50: 1130-1138.
8. American Thoracic Society. Occupational contribution to the burden of airway disease. Am J Respir Crit Care Med 2003; 167: 787-797.
9. Trupin L, Earnest G, San Pedro M, et al. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J 2003; 22: 462-469.
10. Becklake M. Occupational exposures: evidence for a causal association with chronic obstructive pulmonary disease. Am Rev Respir Dis 1989; 140 (Suppl): S85-S91. (Pubitemid 19231341)
11. Oxman A D, Muir D C F, Shannon H S, Stock S R, Hnizdo E, Lange H J. Occupational dust exposure and chronic obstructive pulmonary disease. A systemic overview of the evidence. Am Rev Respir Dis 1993; 148: 38-48.
12. Attfi eld M D. Longitudinal decline in FEV1 in United States coalminers. Thorax 1985; 40: 132-137.
13. Sircar K, Hnizdo E, Petsonk E, Attfi eld M. Decline in lung function and mortality: implication for medical monitoring. Occup Environ Med 2007; 64: 461-466.
14. Beeckman L A, Wang M L, Petsonk E L, Wagner G R. Rapid declines in FEV1 and subsequent respiratory symptoms, illnesses, and mortality in coal miners in the United States. Am J Respir Crit Care Med 2001; 163: 633-639.
15. Cosio M G, Seatta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009; 360: 2445-2454.
16. Anthonisen N R, Connett J E, Murray R P. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002; 166: 675-679.
17. Sin D D, Wu L, Man S F. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005; 127: 1952-1959.
18. Hankinson J L, Wagner G R, Medical screening using periodic spirometry for detection of chronic lung disease [State of the Art Review]. Occup Med 1993; 8: 353-361.
19. Wagner G R. Screening and surveillance of workers exposed to mineral dust. Geneva, Switzerland: World Health Organization, 1996.
20. Harber P, Lockey J E. Pulmonary function testing in pulmonary prevention [State of the Art Review]. Occup Med 1993; 8: 69-79.
21. American College of Occupational and Environmental Medicine. Spirometry in the occupational setting. J Occup Environ Med 2000; 42: 228-245.
22. American College of Occupational and Environmental Medicine, Occupational and Environmental Lung Disorder Committee. ACOEM Position Statement: spirometry in the occupational health setting-2010 update. Evaluating results over time. Elk Grove Village, IL, USA: ACOEM, 2010. www.acoem.org/ guidelines/article.aspx? ID=756 Accessed May 2010.
23. Townsend M C. Evaluating pulmonary function change over time in the occupational setting. ACOEM evidence-based statement. J Occup Environ Med 2005; 47: 1307-1316.
24. Boehlecke B A, Merchant J A. The use of pulmonary function testing and questionnaires as epidemiologic tools in the study of occupational lung disease. Chest 1981; 4 (Suppl): S114-S121.
25. Darkow T, Kadlubek P J, Shah H, Phillips A L, Marton J P. A retrospective analysis of disability and its related costs among employees with chronic obstructive pulmonary disease. J Occup Environ Med 2007; 49: 22-30.
26. Gulati M, Slade M D, Fiellin M G, Cullen M R. Healthcare for obstructive lung disease in an industrial spirometry surveillance program. J Occup Environ Med 2009; 5: 336-342.
27. National Institute for Occupational Safety and Health. Spirometry in the occupational setting: Spirometry Longitudinal Data Analysis (SPIROLA) software. USA: Atlanta, GA, USA: Centers for Disease Control and Prevention, NIOSH, update June 2009. http://www.cdc.gov/niosh/topics/spirometry/spirola.html Accessed April 2010.
28. Hnizdo E, Sircar K, Glindmeyer H W, Petsonk E L. Longitudinal limits of normal decline in lung function in an individual. J Occup Environ Med 2006; 48: 625-634.
29. Hnizdo E, Yan T, Sircar K, Harber P, Fleming J, Glindmeyer H W. Limits of longitudinal decline for the interpretation of annual changes in FEV 1 in individuals. Occup Environ Med 2007; 64: 701-707.
30. Burrows B, Lebowitz M D, Cailli A E, Knudson R J. Longitudinal changes in forced expiratory volume in one second in adults. Methodological considerations and fi nding in healthy nonsmokers. Am Rev Respir Dis 1986; 133: 974-980.
31. Lebowitz M D. Age, period and cohort effects. Infl uences on differences between cross-sectional and longitudinal pulmonary function results. Am J Respir Crit Care Med 1996; 154 (Pt 2): S273-S277. (Pubitemid 26425361)
32. Dockery D W, Ware J H, Ferris B G Jr, et al. Distribution of forced expiratory volume in one second and forced vital capacity in healthy, white, adult never-smokers in six U.S. cities. Am Rev Respir Dis 1985; 131: 511-520.
33. Sherrill D L, Lebowitz M D, Knudson R J, Burrows B. Continuous longitudinal regression equations for pulmonary function measures. Eur Respir J 1992; 5: 452-462.
34. Kauffmann F, Drouet D, Lellouch J, Brille D. Occupational exposure and 12 year spirometric changes among Paris area workers. Br J Ind Med 1982; 39: 221-232. (Pubitemid 12045484)
35. Love R G, Miller B G. Longitudinal study of lung function in coal miners. Thorax 1982; 37: 193-197. (Pubitemid 12154575)
36. Coggon D, Taylor N A. Coal mining and chronic obstructive pulmonary disease: a review of the evidence. Thorax 1998; 53: 398-407. (Pubitemid 28261333)
37. Hodgins P, Henneberger P K, Wang M-L, Petsonk E L. Bronchial responsiveness and five-year FEV1 decline. A study in miners and nonminers. Am J Respir Crit Care Med 1998; 157: 1390-1396.
38. Wang M L, Petsonk E L, Beeckman L A, Wagner G R. Clinically important FEV1 decline among coal miners: an exploration of previously unrecognized determinants. Occup Environ Med 1999; 56: 837-844.
39. Zuskin E, Ivankovic D, Schachter E N, Witek T J. A ten-year follow-up study of cotton textile workers. Am Rev Respir Dis 1991; 143: 301-305.
40. Glindmeyer H W, Lefante J J, Jones R N, Rando R J, Weill H. Cotton dust and across-shift change in FEV1 as predictors of annual change in FEV1. Am J Respir Crit Care Med 1994; 149: 584-590.
41. Ulvestad B, Bakke B, Eduard W, Kongerud J, Lund M B. Cumulative exposure to dust causes accelerated decline in lung function in tunnel workers. Occup Environ Med 2001; 58: 663-669.
42. Bakke B, Ulvestad B, Stewart P, Eduard W. Cumulative exposure to dust and gases as determinants of lung function decline in tunnel construction workers. Occup Environ Med 2004; 61: 262-269.
43. Wang M, McCabe L, Hankinson J L, et al. Longitudinal and cross-sectional analyses of lung function in steelworkers. Am J Respir Crit Care Med 1996; 153: 1907-1913. (Pubitemid 26187919)
44. Mehta A J, Henneberger P K, Toren K, Olin A-C. Airfl ow limitation and changes in pulmonary function among bleachery workers. Eur Respir J 2005; 26: 133-139.
45. Harber P, Tashkin D P, Simmons M, Crawford L, Hnizdo E, Connett J. Effect of occupational exposures on decline of lung function in early COPD. Am J Respir Crit Care Med 2007; 176: 994-1000.
46. Musk A W, Peters J M, Bernstain L, Rubin C, Monroe C B. Pulmonary function in fi refi ghters: a six-year follow-up in the Boston fi re department. Am J Indust Med 1982; 3: 3-9.
47. Pahwa P, Senthilselvan A, McDuffi e H H, Dosman J A. Longitudinal decline in lung function measurements among Saskatchewan grain workers. Can Respir J 2003; 10: 135-141.
48. Fletcher C, Peto R, Tinker C, Speizer F E. The natural history of chronic bronchitis and emphysema. New York, NY, USA: Oxford University Press, 1976.
49. Blanc P D, Eisner M D, Earnest G, et al. Further exploration of the links between occupational exposure and chronic obstructive pulmonary disease. J Occup Environ Med 2009; 51: 804-810.
50. Hnizdo E. Combined effect of silica dust and tobacco smoking on mortality from chronic obstructive lung disease in gold miners. Br J Ind Med 1990; 47: 656-664. (Pubitemid 20298465)
51. McClean K M, Kee F, Young I S, Elborn J S. Obesity and lung function: 1. Epidemiology. Thorax 2008; 63: 649-654.
52. McClean K M, Cardwell C R, Kee F, et al. Longitudinal changes in BMI and lung function in middle-aged men in Northern Ireland. Ir J Med Sci 2007; 176 (Suppl 10): S418.
53. Chen Y, Rennie D, Cormier Y F, et al. Waist circumference is associated with pulmonary function in normal-weight, overweight, and obese subjects. Am J Clin Nutr 2007; 85: 35-39.
54. Leone N, Courbon D, Thomas F, et al. Lung function impairment and metabolic syndrome. Critical role of abdominal obesity. Am J Respir Crit Care Med 2009; 179: 509-516.
55. Berry G. Longitudinal observations. Their usefulness and limitations with special reference to the forced expiratory volume. Bull Physiopathol Respir 1974; 10: 643-655.
56. Glindmeyer H W, Jones R N, Diem J E, Weil H. Useful and extraneous variability in longitudinal assessment of lung function. Chest 1987; 92: 877-882.
57. Becklake M R, White N. Sources of variation in spirometric measurements. Identifying the signal and dealing with noise. Occup Med 1993; 8: 241-264.
58. Neter J, Wasserman W. Applied linear statistical models. Homewood, IL, USA: Richard D Irwin, 1974.
59. Schlesselman J J. Planning a longitudinal study: II. Frequency of measurement and study duration. J Chron Dis 1973; 26: 553-558.
60. Hnizdo E, Yu L, Freyder L, Lefante J, Glindmeyer H W. Precision of longitudinal lung function measurements-monitoring and interpretation. Occup Environ Med 2005; 62: 695-701.
61. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202-1218.
62. Wang M, Petsonk E L. Repeated measures of FEV1 over six to twelve months: what change is abnormal? J Occup Environ Med 2004; 46: 591-595.
63. Wang M L, Vashia B H, Petsonk L E. Interpreting periodic lung function tests in individuals. The relationship between 1- to 5-year and long-term FEV1 changes. Chest 2006; 130: 493-499.
64. Miller M R, Hankinson J, Brusasco V, et al. Standardization of spirometry. Standardization of lung function testing. Eur Respir J 2005; 26: 319-338.
65. Enright P L, Johnson L R, Connett J E, Voelker H, Buist A S. Spirometry in the Lung Health Study. 1. Methods and quality control. Am Rev Respir Dis 1991; 143: 1215-1223.
66. National Institute for Occupational Safety and Health. Spirometry in the occupational setting: NIOSH spirometry training course. Atlanta, GA, USA: Centers for Disease Control and Prevention, NIOSH, 2009. http://www.cdc.gov/ niosh/topics/ spirometry Accessed April 2010.
67. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
68. Wang M-L, Wu Z-E, Du Q-G, et al. A prospective cohort study among new Chinese coal miners: the early pattern of lung function change. Occup and Environ Med 2005; 62: 800-805.
69. Kreiss K, Gomaa A, Kullman G, Fedan K, Simoes E J, Enright P L. Clinical bronchiolitis obliterans in workers at a microwavepopcorn plant. N Eng J Med 2002; 347: 330-338.
70. Harber P, Levine J, Bansal S. How frequently should workplace spirometry screening be performed? Optimization via analytical models. Chest 2009; 136: 1086-1094.